Ferumoxytol and Gadolinium Magnetic Resonance Imaging (MRI) at 3 Tesla (T) and 7 Tesla (T) in Patients With Malignant Brain Tumors

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2015 by OHSU Knight Cancer Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Information provided by (Responsible Party):
OHSU Knight Cancer Institute
ClinicalTrials.gov Identifier:
First received: April 10, 2008
Last updated: July 20, 2015
Last verified: July 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: May 2016
  Estimated Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)